Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune

Trial Profile

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 03 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 22 Jul 2015 Planned End Date changed from 1 Sep 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.
    • 22 Jul 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top